Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.32 |
| ▸ | NEK2 | P51955 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
| ▸ | GLI1 | P08151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2234044 | 0.81 | FAAH (0.32) | MAPTTSHRFAAHMEN1KMT2A | |
| SCHEMBL11792582 | 0.80 | FAAH (0.40) | MAPTALDH1A1GAATP53TSHR | |
| SCHEMBL5909047 | 0.80 | FAAH (0.38) | MAPTALDH1A1TSHRFAAHMEN1 | |
| SCHEMBL26108908 | 0.75 | MEN1 (0.42) | MAPTTSHRFAAHMEN1KMT2A | |
| SCHEMBL11685520 | 0.73 | KDM4E (0.37) | MAPTALDH1A1GAATP53TSHR | |
| SCHEMBL16597319 | 0.71 | MEN1 (0.54) | MAPTALDH1A1GAATSHRSMN1; SMN2 | |
| SCHEMBL29760847 | 0.71 | KDM1A (0.44) | GAAFAAHMEN1KMT2ANPSR1 | |
| SCHEMBL2279716 | 0.71 | KDM1A (0.44) | GAAFAAHMEN1KMT2ANPSR1 | |
| SCHEMBL9778659 | 0.70 | L3MBTL1 (0.47) | TSHRMEN1KMT2AHTR2AL3MBTL1 | |
| SCHEMBL30669509 | 0.70 | L3MBTL1 (0.47) | TSHRMEN1KMT2AHTR2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7981990-B2 | Synthesis of a liquid polymer and a functionalized polymer | BRIDGESTONE CORPORATION (JP) | 2011-07-19 | — | — | US | claimed |
| JP-2010538109-A | — | — | 2010-12-09 | — | — | JP | claimed |
| EP-2193150-A2 | SYNTHESIS OF A LIQUID POLYMER AND A FUNCTIONALIZED POLYMER | Bridgestone Corporation (JP) | 2010-06-09 | — | — | EP | claimed |
| WO-2009032154-A2 | SYNTHESIS OF A LIQUID POLYMER AND A FUNCTIONALIZED POLYMER | BRIDGESTONE CORPORATION (JP) | 2009-03-12 | — | — | WO | claimed |
| US-20090062451-A1 | SYNTHESIS OF A LIQUID POLYMER AND A FUNCTIONALIZED POLYMER | BRIDGESTONE CORPORATION (JP) | 2009-03-05 | — | — | US | claimed |
| EP-2193150-B1 | SYNTHESIS OF A LIQUID POLYMER AND A FUNCTIONALIZED POLYMER | BRIDGESTONE CORP (JP) | 2020-09-23 | — | — | EP | disclosed |
| EP-2266993-B1 | The use of sulfur containing initiators for anionic polymerization of monomers | BRIDGESTONE CORP (JP) | 2017-06-14 | — | — | EP | disclosed |
| EP-2658898-B1 | COUPLED POLYMERS AND METHODS FOR MAKING SAME | BRIDGESTONE CORP (JP) | 2016-10-12 | — | — | EP | disclosed |
| US-9441097-B2 | Rubber composition and tire produced by using the same | BRIDGESTONE CORPORATION (JP) | 2016-09-13 | — | — | US | disclosed |
| EP-2657282-B1 | RUBBER COMPOSITION AND TIRE PRODUCED BY USING THE SAME | BRIDGESTONE CORP (JP) | 2016-08-24 | — | — | EP | disclosed |
| US-9221923-B2 | Coupled polymers and methods for making same | BRIDGESTONE CORPORATION (JP) | 2015-12-29 | — | — | US | disclosed |
| EP-1565476-B1 | THE USE OF SULFUR CONTAINING INITIATORS FOR ANIONIC POLYMERIZATION OF MONOMERS | BRIDGESTONE CORP (JP) | 2015-03-25 | — | — | EP | disclosed |
| US-20080004385-A1 | Sulfur containing initiators for anionic polymerization of monomers | BRIDGESTONE CORPORATION | 2008-01-03 | — | — | US | disclosed |
| EP-1805223-A1 | FUNCTIONALIZED POLYMER WITH LINKING GROUP | Bridgestone Corporation (JP) | 2007-07-11 | — | — | EP | disclosed |
| US-20070083023-A1 | Use of sulfur containing initiators for anionic polymerization of monomers | BRIDGESTONE CORPORATION | 2007-04-12 | — | — | US | disclosed |
| US-7153919-B2 | Use of sulfur containing initiators for anionic polymerization of monomers | BRIDGESTONE CORPORATION (JP) | 2006-12-26 | — | — | US | disclosed |
| WO-2006047328-A1 | FUNCTIONALIZED POLYMER WITH LINKING GROUP | BRIDGESTONE CORPORATION (JP) | 2006-05-04 | — | — | WO | disclosed |
| US-20060030657-A1 | Use of sulfur containing initiators for anionic polymerization of monomers | BRIDGESTONE CORPORATION (JP) | 2006-02-09 | — | — | US | disclosed |
| EP-1565476-A2 | THE USE OF SULFUR CONTAINING INITIATORS FOR ANIONIC POLYMERIZATION OF MONOMERS | Bridgestone Corporation (JP) | 2005-08-24 | — | — | EP | disclosed |
| WO-2004041870-A2 | THE USE OF SULFUR CONTAINING INITIATORS FOR ANIONIC POLYMERIZATION OF MONOMERS | BRIDGESTONE CORPORATION (JP) | 2004-05-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062451-A1 | SYNTHESIS OF A LIQUID POLYMER AND A FUNCTIONALIZED POLYMER | FGB, FIP1L1, PUF60 | MAPT 2672/4885ALDH1A1 1640/4885GAA 2367/4885 |
| US-20060030657-A1 | Use of sulfur containing initiators for anionic polymerization of monomers | TST, ESD, VCL | MAPT 2123/4885ALDH1A1 3070/4885GAA 2410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.